NYC’s Leading Integrative Health Care Center
NYC’s Leading Integrative Health Care Center
Medically reviewed by Rashmi Gulati, MD — Last updated: August 6, 2026
Gastrointestinal issues can affect the stomach, intestines, and digestive system, causing symptoms such as bloating, reflux, abdominal discomfort, or changes in bowel habits. Identifying the underlying cause is an important part of effective care.
Gastrointestinal issues occur when the gut microbiome, digestive enzymes, and intestinal lining fall out of balance, disrupting how the body breaks down food, absorbs nutrients, and regulates inflammation. For the patient, this often means years of bloating, unpredictable bowel habits, and being told test results look “normal” while symptoms persist.
Board-certified integrative medicine physician.
Gastrointestinal issues describe a spectrum of chronic digestive dysfunctions — including bloating, irregular motility, food reactivity, and intestinal barrier dysfunction — that arise from imbalances in the gut microbiome, digestive enzyme output, gut-immune signaling, and the gut-brain axis. The term covers overlapping functional and inflammatory patterns, such as SIBO, dysbiosis, and increased intestinal permeability, that often precede or accompany formal diagnoses like IBS or IBD.
Gastrointestinal issues is an umbrella description for chronic, often fluctuating digestive symptoms that arise before or alongside a formal diagnosis. Rather than one disease, it is a pattern of dysfunction — the gut’s ecosystem of bacteria, its enzyme output, and the integrity of its lining have shifted away from a state that supports smooth digestion, consistent nutrient absorption, and calm immune signaling.
Mechanistically, three systems tend to break down together. First, the microbiome shifts toward species that ferment food inefficiently, producing excess hydrogen or methane gas that causes bloating and altered motility. Second, digestive capacity drops — stomach acid, pancreatic enzymes, and bile flow all decline under chronic stress, leaving food partially undigested and available for bacterial overgrowth. Third, the single-cell-thick intestinal lining, held together by tight junction proteins, becomes more permeable, allowing bacterial fragments and undigested proteins to cross into the bloodstream and trigger low-grade systemic inflammation.
Conventional gastroenterology generally waits until symptoms cluster into a named syndrome, such as irritable bowel syndrome, before intervening, and its diagnostic tools are built to rule out structural disease like inflammatory bowel disease or cancer rather than to characterize functional imbalance. Functional medicine recognizes this same dysfunction earlier by directly testing the microbiome, motility, and gut barrier, which is why two patients with an identical IBS diagnosis can have entirely different underlying drivers and require different treatment.
Digestive complaints of this kind are extremely common — a large share of American adults report chronic bloating, irregular bowel habits, or food reactivity in any given year, and women are affected somewhat more often than men, likely reflecting the influence of estrogen and progesterone on gut motility and visceral sensitivity.
A single layer of cells lining the small intestine, joined by tight junction proteins that control what passes into the bloodstream. When these junctions loosen, increased intestinal permeability allows bacterial fragments to trigger systemic inflammation.
The trillions of bacteria, fungi, and archaea residing primarily in the colon and small intestine that ferment fiber, synthesize vitamins, and regulate immune tone. Overgrowth or depletion of key species drives gas production and inflammation.
Often called the “second brain,” this network of over 100 million neurons in the gut wall governs motility and communicates bidirectionally with the brain via the vagus nerve, linking chronic stress directly to digestive symptoms.
Gastrointestinal issues produce a wide symptom footprint because the gut interacts directly with the immune, nervous, and endocrine systems — so the same underlying dysfunction can show up as digestive discomfort in one patient and as skin or cognitive symptoms in another.
Bacterial fermentation of undigested carbohydrates produces hydrogen and methane gas that stretches the intestinal wall.
Methane-producing organisms slow transit time, while hydrogen-dominant overgrowth accelerates it.
Reflects bacterial overgrowth fermenting food before the small intestine can absorb it.
Visceral hypersensitivity from gut-nerve signaling amplifies normal digestive contractions into pain.
Increased intra-abdominal pressure from bloating can push stomach contents upward.
Circulating inflammatory cytokines from a permeable gut lining cross into the central nervous system and impair clarity.
Reduced serotonin and GABA precursor availability, both partly gut-produced, affects neurotransmission.
The vagus nerve carries inflammatory and microbial signals directly to mood-regulating brain regions.
Dysregulated gut-produced melatonin precursors and nighttime bloating interfere with sleep onset.
Systemic inflammation is associated with reduced dopaminergic signaling.
Malabsorption of B vitamins and iron reduces cellular energy production.
Altered microbial calorie extraction and appetite-hormone signaling shift energy balance.
Reduced digestive enzyme output limits breakdown and absorption of protein, fat, and micronutrients.
Circulating lipopolysaccharides from a leaky gut trigger low-grade systemic inflammation in joint tissue.
Gut-skin axis signaling links intestinal inflammation to acne, rosacea, and eczema.
A permeable gut lining exposes the immune system to undigested proteins it wouldn't normally encounter, triggering IgG reactions.
Roughly 70% of immune tissue sits in the gut wall, so gut inflammation weakens systemic immune surveillance.
Certain dysbiotic bacteria overproduce histamine, causing flushing, headaches, and hives.
Reduced regulatory T-cell activity from dysbiosis lowers the threshold for allergic responses.
Molecular mimicry from gut bacterial proteins can intensify existing autoimmune activity.
Identifying which pattern — or combination of patterns — is driving your symptoms determines which tests and treatments will actually help, since a protocol built for bacterial overgrowth can worsen a purely motility-based case, and vice versa.
Structural imaging and standard labs appear normal, but the gut-brain axis has become hypersensitive, amplifying ordinary digestive sensations into pain and urgency. Symptoms often flare with stress and improve with vagal and nervous-system-focused therapy.
Bacteria that normally reside in the colon migrate into or overgrow within the small intestine, fermenting food prematurely and producing hydrogen or methane gas. Bloating is typically worse after meals rich in fermentable carbohydrates.
Tight junction proteins in the intestinal lining loosen, allowing bacterial fragments and undigested food particles into circulation, triggering systemic inflammation, new food sensitivities, and extra-intestinal symptoms like joint pain or skin flares.
The migrating motor complex, which sweeps residual food and bacteria through the small intestine between meals, functions poorly, allowing bacteria and food residue to accumulate and predisposing patients to relapsing SIBO.
Most cases of gastrointestinal dysfunction arise from several interacting causes rather than one isolated trigger, which is why identifying your specific combination of drivers — not just naming a syndrome — is the foundation of an effective protocol.
Broad-spectrum antibiotics reduce microbial diversity, creating room for opportunistic bacteria and yeast to overgrow.
Sustained cortisol elevation reduces digestive blood flow, enzyme output, and gut barrier integrity via the HPA axis.
Certain bacterial toxins (e.g., cytolethal distending toxin) damage the gut’s migrating motor complex, predisposing to SIBO.
Regular ibuprofen or aspirin use directly damages the intestinal lining and increases permeability.
Reduced hydrochloric acid output, common with PPI use or aging, allows bacteria to survive into the small intestine.
A narrow range of plant fibers starves beneficial bacterial species that produce anti-inflammatory short-chain fatty acids.
Low thyroid hormone slows intestinal motility, allowing bacterial overgrowth to develop over time.
Alcohol directly disrupts tight junction proteins, increasing intestinal permeability.
Adhesions or altered anatomy can create areas of stasis where bacteria accumulate.
Mycotoxins impair bile flow and detoxification pathways that normally support gut health.
Conditions like Hashimoto’s or type 1 diabetes are strongly associated with increased intestinal permeability.
Disrupted circadian rhythm alters the timing of the migrating motor complex and microbial composition.
Because symptoms overlap heavily across digestive diagnoses, distinguishing between them requires looking past the symptom pattern to the specific biomarker or test result that separates one condition from another.
| Condition | Key Biomarker | Best Diagnostic Test | Hallmark Symptom | Standard Blood Test Detection | Treatment Approach |
|---|---|---|---|---|---|
| GI Issues (general) | Elevated zonulin / abnormal stool markers | Comprehensive stool analysis (GI-MAP) | Fluctuating bloating & irregularity | Usually normal | Root-cause functional protocol |
| Irritable Bowel Syndrome | Symptom-based (Rome IV criteria) | Clinical diagnosis of exclusion | Pain tied to bowel changes | Normal | Symptom management + diet (low-FODMAP) |
| SIBO | Elevated breath hydrogen/methane | Lactulose or glucose breath test | Post-meal bloating | Normal | Antimicrobial herbs or rifaximin |
| Inflammatory Bowel Disease | Elevated fecal calprotectin, CRP | Colonoscopy with biopsy | Bloody stool, weight loss | Often abnormal (CRP, CBC) | Immunosuppressive / biologic therapy |
The most clinically important overlap is between general gastrointestinal dysfunction and Irritable Bowel Syndrome: a large proportion of patients carrying an IBS diagnosis test positive for SIBO on breath testing, meaning the IBS label described the symptom pattern without identifying its bacterial driver.
Our position: Structural disease must always be ruled out first, and we work alongside conventional gastroenterology to ensure that happens. Once serious pathology is excluded, we believe functional testing offers patients real, actionable answers for symptoms that are otherwise dismissed as “normal” — and we say so plainly rather than overselling either side.
Uses DNA-based technology to profile bacterial, fungal, and parasitic organisms alongside markers of inflammation (calprotectin), digestive function (elastase), and immune activity (secretory IgA) — detail standard stool cultures miss entirely.
Measures hydrogen and methane gas produced by bacteria after a lactulose or glucose challenge, identifying small intestinal bacterial overgrowth that a colonoscopy or standard blood panel cannot detect.
Measures zonulin, a protein that regulates tight junction integrity, to assess whether the intestinal lining has become more porous than normal — a key driver of new food sensitivities and systemic inflammation.
Identifies delayed immune reactions to specific foods that may be perpetuating gut inflammation, distinct from a true IgE food allergy and often missed by standard allergy testing.
Analyzes urinary byproducts of bacterial and yeast metabolism to flag fungal or bacterial overgrowth and nutrient cofactor deficiencies affecting digestive enzyme production.
Check all that apply to your current experience:
Every protocol is built from your specific stool, breath, and permeability test results — not a generic supplement stack — because treating the wrong pattern (for example, adding fiber-heavy probiotics into active SIBO) can make symptoms measurably worse.
Targeted herbal antimicrobials reduce bacterial or fungal overgrowth identified on testing, offering an alternative or complement to pharmaceutical antibiotics like rifaximin.
Strain-specific probiotics are selected based on your microbiome results to rebuild beneficial populations without feeding a confirmed overgrowth pattern.
Specific nutraceuticals supply the amino acids and minerals the intestinal epithelium needs to rebuild tight junctions and reduce permeability.
Enzyme and bile acid supplementation restores the breakdown capacity needed to properly digest fats, proteins, and carbohydrates before they reach the colon.
For patients with confirmed deficiencies from malabsorption, IV vitamin therapy bypasses an impaired gut to restore nutrient status while oral healing continues.
Structured breathing and biofeedback techniques improve vagal tone, which governs the migrating motor complex and reduces visceral hypersensitivity over time.
Weeks 1–4: Initial dietary adjustment and, if indicated, an antimicrobial phase begins; bloating and gas often shift first. Weeks 4–12: Bowel regularity and energy typically stabilize as the microbiome rebalances. Months 3–9: For permeability-driven cases, gut lining repair and food reintroduction continue, with biomarkers (zonulin, calprotectin, breath test) rechecked at defined intervals to confirm objective progress rather than relying on symptoms alone.
Spend 10 minutes before each main meal on slow diaphragmatic breathing (4 seconds in, 7 seconds hold, 8 seconds out) to shift the nervous system out of sympathetic "fight or flight" mode, which directly increases digestive enzyme and bile release.
Space meals so the migrating motor complex — the gut's "housekeeping wave" — can complete its 90-minute sweeping cycle between meals, reducing the residue available for bacterial overgrowth.
Light post-meal movement stimulates peristalsis and reduces the intra-abdominal pressure that contributes to bloating and reflux, without the digestive slowdown caused by lying down.
Go to bed and wake within the same 30-minute window daily; circadian misalignment disrupts the timing of the migrating motor complex and microbial gene expression tied to gut barrier repair.
Mechanical breakdown in the mouth combined with salivary amylase reduces the digestive workload on the stomach and small intestine, directly lowering post-meal bloating.
Both introduce excess air into the digestive tract and, in gum's case, artificial sweeteners like sorbitol that are poorly absorbed and readily fermented by gut bacteria, worsening gas.
Diet matters mechanistically because every meal either feeds a balanced microbiome and supports gut lining repair, or feeds bacterial overgrowth and perpetuates inflammation — the same food can do either, depending on your specific pattern.
Identify and temporarily remove your specific trigger foods through a structured elimination protocol before adding in gut-repair supplements layering repair nutrients on top of an ongoing trigger exposure blunts the results of both.
The following conditions frequently coexist with or emerge from unresolved gastrointestinal dysfunction:
IBS is frequently the diagnostic label applied once GI dysfunction meets symptom-based criteria, and a large share of IBS cases test positive for underlying SIBO.
Increased intestinal permeability is one of the four core mechanistic patterns within gastrointestinal issues and is directly tested via zonulin panels.
Fungal overgrowth often coexists with bacterial dysbiosis, particularly after antibiotic courses, and shares many overlapping symptoms like bloating and fatigue.
Chronic HPA-axis dysregulation reduces digestive blood flow and enzyme output, making adrenal and gut dysfunction frequent co-travelers.
Autoimmune thyroid conditions are strongly associated with increased intestinal permeability and slowed motility that predisposes to bacterial overgrowth.
Malabsorption of B vitamins and iron from ongoing gut dysfunction is a common, often overlooked contributor to persistent fatigue.
Occasional digestive discomfort is common, but persistent or escalating symptoms deserve a proper functional medicine workup rather than ongoing guesswork.
Seek immediate medical evaluation for: Blood in the stool, unintentional weight loss, persistent vomiting, severe or worsening abdominal pain, difficulty swallowing, or a family history of colorectal cancer with new symptoms after age 45 — these require prompt evaluation to rule out structural or urgent conditions before any functional workup begins.
Individual results vary. Shared with patient permission; names abbreviated for privacy.
Yes. Gastrointestinal issues are a recognized cluster of digestive dysfunctions rooted in measurable physiological changes — altered gut microbiome composition, small intestinal bacterial overgrowth, impaired digestive enzyme output, and increased intestinal permeability. While “gastrointestinal issues” is not itself a single ICD-coded diagnosis the way irritable bowel syndrome or Crohn’s disease is, it describes the underlying dysfunction that shows up on stool testing, breath testing, and blood work well before or alongside those formal diagnoses. Conventional gastroenterology tends to name the downstream syndrome once symptoms cluster into a recognizable pattern, such as IBS or GERD, while functional medicine treats the upstream dysfunction directly. At Patients Medical, we validate what patients already know from experience: the symptoms are real, they have identifiable biological drivers, and they respond to treatment when the right root causes are addressed rather than only managed.
Most patients notice initial improvement in bloating, bowel regularity, and energy within 4 to 6 weeks of starting a personalized protocol, though the full timeline depends on how long the dysfunction has been present and which patterns are involved. Straightforward dysbiosis or short-term food reactivity often responds within 6 to 12 weeks. SIBO typically requires a longer arc — an initial antimicrobial phase of 4 to 6 weeks, followed by 2 to 3 months of motility support and dietary sequencing to prevent relapse, since SIBO recurs in a substantial share of patients without addressing the underlying motility issue. Cases involving intestinal permeability and secondary food sensitivities generally take 4 to 9 months to fully resolve, because the intestinal lining needs sustained nutritional support to rebuild. We recheck relevant biomarkers at defined intervals rather than guessing, so you and your physician always know where you stand in the process.
There is no single test, because gastrointestinal issues reflect several possible overlapping mechanisms. A comprehensive stool analysis, such as the GI-MAP, profiles bacterial, fungal, and parasitic organisms along with markers of inflammation (calprotectin), digestion (elastase, fat content), and immune activity (secretory IgA). A SIBO breath test measures hydrogen and methane gas after a lactulose or glucose challenge to detect small intestinal bacterial overgrowth. Intestinal permeability testing measures zonulin and related markers to assess whether the gut lining has become more porous than normal. An IgG food sensitivity panel identifies delayed immune reactions to specific foods that may be perpetuating inflammation. Standard blood work — including CRP, CBC, and a metabolic panel — is also reviewed, since it can rule out or flag conditions such as celiac disease or inflammatory bowel disease that require a different treatment path entirely.
Yes, and this connection is often overlooked. Chronic dysbiosis alters the ratio of bacterial species that extract calories from food and influence appetite-regulating hormones like GLP-1 and PYY, which can promote fat storage independent of calorie intake. Low-grade intestinal inflammation raises circulating cortisol and inflammatory cytokines such as TNF-alpha, both of which are associated with increased abdominal adiposity and insulin resistance. SIBO-driven bloating is frequently mistaken for fat gain, and the associated malabsorption can paradoxically coexist with weight gain when nutrient deficiencies drive persistent cravings and blood sugar instability. Many patients who have struggled to lose weight despite disciplined diet and exercise find that addressing the underlying gut dysfunction — rather than further restricting calories — is what finally allows their weight to respond to lifestyle changes.
Irritable bowel syndrome is a specific, symptom-based diagnosis made when a patient meets the Rome IV criteria — recurrent abdominal pain associated with a change in stool frequency or form — after other conditions have been ruled out. Gastrointestinal issues is a broader, mechanism-based description that includes IBS but also covers dysbiosis, SIBO, and intestinal permeability that may not yet meet IBS’s diagnostic threshold, or that coexist with an IBS diagnosis as its underlying driver. In practice, a large share of patients diagnosed with IBS test positive for SIBO on breath testing, meaning the IBS label described their symptom pattern without identifying the bacterial overgrowth causing it. Functional medicine testing is designed to look underneath a symptom-based label like IBS to find and treat the specific mechanism at work in each patient.
Roughly 70 percent of the body’s immune tissue, known as gut-associated lymphoid tissue, sits directly beneath the intestinal lining, so disruptions to that lining have immediate immune consequences. When intestinal permeability increases, bacterial fragments called lipopolysaccharides can cross into circulation and trigger a systemic low-grade inflammatory response, which has been linked to skin conditions including acne, rosacea, and eczema flare-ups. The gut microbiome also produces short-chain fatty acids like butyrate that regulate immune cell activity throughout the body; when the bacterial populations producing these compounds are depleted, immune regulation weakens and inflammatory skin and joint symptoms often follow. Patients frequently describe their skin clearing or their seasonal allergies easing once gut inflammation is brought down, which reflects this shared immune pathway rather than a coincidence.
Support is sequenced rather than combined all at once, because taking the wrong intervention at the wrong stage can worsen symptoms. Early-stage support often includes digestive enzymes and betaine HCl to improve nutrient breakdown, along with targeted antimicrobial herbs such as berberine, oregano oil, or neem when SIBO or dysbiosis is confirmed on testing. Once overgrowth is addressed, a spore-based or soil-based probiotic is typically introduced to help re-establish a healthy microbial baseline without feeding a recurring overgrowth. Gut lining repair relies on L-glutamine, zinc carnosine, deglycyrrhizinated licorice (DGL), and collagen peptides, which supply the specific building blocks the intestinal epithelium uses to regenerate. IV vitamin therapy can also be used short-term to correct nutrient deficiencies while oral absorption is still impaired. Every protocol at Patients Medical is built from your specific stool, breath, and blood test results rather than a generic supplement stack, since taking the wrong probiotic strain for your pattern can actively worsen bloating.
Patients Medical combines advanced functional testing with physician-guided, personalized protocols — so you get a specific answer for your gut, not a generic elimination diet.
Call us at (212) 794-8800 · 800 Second Avenue, Suite 900, New York, NY 10017
Patients Medical specializes in gently helping the patient identify the root cause of their medical issues and then assist them to recover from their problems to help them move forward to good health.
To schedule an in person on Tele-medicine appointment, please call our office at (212) 794-8800 or email us at info@PatientsMedical.com We look forward to hearing from you
Patients Medical PC
1148 Fifth Avenue, Suite 1B New York, NY 10128
Copyright © 2026 Patients Medical. All Rights Reserved.
All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease. Patients Medical.
Disclaimer: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE AND MAY BE OUT OF DATE. The information, including but not limited to text, PDFs, graphics, images, and other material contained on this website, is for general educational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment, and does not create a patient-doctor relationship. Pricing on the website may be out of date, is subject to change without notice, and may be subject to additional terms and conditions. No information on this site is intended to be a financial quote for medical services. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition, lifestyle or dietary changes, treatments, and before undertaking a new healthcare regimen. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
